Salmoiraghi et al. reported TP53 mutations in 14 of 171 (8%) adult Philadelphia-negative ALL cases, interrelated with worse OS and higher cumulative incidence of relapse (CIR) [350]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.